Tivozanib, sold under the brand name Fotivda, is a medication used for the treatment of relapsed or refractory advanced renal cell carcinoma. It is an oral VEGF receptor tyrosine kinase inhibitor. Reference standards of Tivozanib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Tivozanib - API Standards [catalogue_number] => PA 73 42000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 454.86 [form] => C22H19ClN4O5 [cas] => 475108-18-0 [pslug] => 475108-18-0-tivozanib-api-pa7342000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 73 42000
CAS :
Molecular Formula : C22H19ClN4O5
Molecular Weight : 454.86
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....